Alflutop®

Active substance:

bioactive concentrate from small marine fish

Pharmachologic effect:

chondroprotective.

Pharmacodynamics:

Alflutop is a chondroprotector, the active component of which is a bioactive concentrate from small marine fish. The concentrate contains mucopolysaccharides (chondroitin sulfate), amino acids, peptides, sodium, potassium, calcium, magnesium, iron, copper and zinc ions.
Alflutop prevents the destruction of macromolecular structures of normal tissues, stimulates recovery processes in the interstitial tissue and articular cartilage tissue, which explains its analgesic effect.
The anti-inflammatory effect and tissue regeneration are based on inhibition of hyaluronidase activity and normalization of hyaluronic acid biosynthesis.
Both of these effects are synergistic and cause the activation of regenerative processes in tissues (in particular, restoration of the cartilage structure).

Indications:

Alflutop is used in adults with the following conditions and diseases:
- primary and secondary osteoarthritis of various localization (coxarthrosis, gonarthrosis, arthrosis of small joints);
- osteochondrosis;
- spondylosis.

Contraindications:

hypersensitivity to the components of the drug; pregnancy; breastfeeding period;
children under 18 years of age (due to the lack of clinical data in this category of patients).

Pregnancy and breast-feeding:

The use of the drug during pregnancy and during breastfeeding is contraindicated.

Side effects:

Rarely - itchy dermatitis, redness of the skin and a burning sensation at the injection site, short-term myalgia;
Very rarely - anaphylactic reactions;

Dosing and Administration:

Polyosteoarthrosis and osteochondrosis : the drug is administered deep intramuscularly - 1 ml per day, the course of treatment is 20 injections (1 injection per day for 20 days) or 2 ml every other day, the course of treatment is 10 injections (1 injection every other day in within 20 days).
Predominant lesion of large joints : 1-2 ml in each joint with an interval of 3-4 days, intra-articularly. Total for the course - 5-6 injections in each joint.
A combination of intra-articular and intramuscular methods of administration is allowed.
It is advisable to repeat the course of treatment after 6 months, after consulting a doctor.

Write a review

Please login to review